JP2018537499A5 - - Google Patents

Download PDF

Info

Publication number
JP2018537499A5
JP2018537499A5 JP2018531388A JP2018531388A JP2018537499A5 JP 2018537499 A5 JP2018537499 A5 JP 2018537499A5 JP 2018531388 A JP2018531388 A JP 2018531388A JP 2018531388 A JP2018531388 A JP 2018531388A JP 2018537499 A5 JP2018537499 A5 JP 2018537499A5
Authority
JP
Japan
Prior art keywords
diffraction pattern
ray powder
powder diffraction
polymorph
radiation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018531388A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018537499A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/067164 external-priority patent/WO2017106642A1/en
Publication of JP2018537499A publication Critical patent/JP2018537499A/ja
Publication of JP2018537499A5 publication Critical patent/JP2018537499A5/ja
Priority to JP2021191696A priority Critical patent/JP2022031797A/ja
Pending legal-status Critical Current

Links

JP2018531388A 2015-12-17 2016-12-16 置換5,6−ジヒドロ−6−フェニルベンゾ[f]イソキノリン−2−アミン化合物の固体形態 Pending JP2018537499A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021191696A JP2022031797A (ja) 2015-12-17 2021-11-26 置換5,6-ジヒドロ-6-フェニルベンゾ[f]イソキノリン-2-アミン化合物の固体形態

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562268747P 2015-12-17 2015-12-17
US62/268,747 2015-12-17
PCT/US2016/067164 WO2017106642A1 (en) 2015-12-17 2016-12-16 Solid forms of substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021191696A Division JP2022031797A (ja) 2015-12-17 2021-11-26 置換5,6-ジヒドロ-6-フェニルベンゾ[f]イソキノリン-2-アミン化合物の固体形態

Publications (2)

Publication Number Publication Date
JP2018537499A JP2018537499A (ja) 2018-12-20
JP2018537499A5 true JP2018537499A5 (enExample) 2020-01-16

Family

ID=59057612

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018531388A Pending JP2018537499A (ja) 2015-12-17 2016-12-16 置換5,6−ジヒドロ−6−フェニルベンゾ[f]イソキノリン−2−アミン化合物の固体形態
JP2021191696A Pending JP2022031797A (ja) 2015-12-17 2021-11-26 置換5,6-ジヒドロ-6-フェニルベンゾ[f]イソキノリン-2-アミン化合物の固体形態

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021191696A Pending JP2022031797A (ja) 2015-12-17 2021-11-26 置換5,6-ジヒドロ-6-フェニルベンゾ[f]イソキノリン-2-アミン化合物の固体形態

Country Status (19)

Country Link
US (3) US9981921B2 (enExample)
EP (2) EP3390369B1 (enExample)
JP (2) JP2018537499A (enExample)
KR (1) KR20180086508A (enExample)
CN (1) CN108368061A (enExample)
AU (2) AU2016369523B2 (enExample)
BR (1) BR112018012095A2 (enExample)
CA (1) CA3006081A1 (enExample)
EA (2) EA036295B1 (enExample)
ES (1) ES2935818T3 (enExample)
HK (1) HK1256825A1 (enExample)
IL (1) IL259556B2 (enExample)
MX (2) MX394320B (enExample)
NZ (1) NZ742695A (enExample)
PH (2) PH12018501246A1 (enExample)
SA (1) SA518391805B1 (enExample)
SG (1) SG11201804670PA (enExample)
TW (2) TWI771280B (enExample)
WO (1) WO2017106642A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017106639A1 (en) 2015-12-17 2017-06-22 Arqule, Inc. Methods for preparing substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine
TWI771280B (zh) 2015-12-17 2022-07-21 美商亞闊股份有限公司 經取代之5,6-二氫-6-苯基苯并[f]異喹啉-2-胺化合物之固體形式
WO2022053708A1 (en) 2020-09-14 2022-03-17 Basilea Pharmaceutica International AG Pharmaceutical combinations for use in the treatment of gastric adenocarcinoma
JP7641247B2 (ja) 2022-03-02 2025-03-06 日立建機株式会社 機械の性能診断装置

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
WO1998028281A1 (en) 1996-12-23 1998-07-02 Celltech Therapeutics Limited Fused polycyclic 2-aminopyrimidine derivatives, their preparation and their use as protein tyrosine kinase inhibitors
GB9713087D0 (en) * 1997-06-20 1997-08-27 Celltech Therapeutics Ltd Chemical compounds
EP1638937B1 (en) * 2003-06-18 2008-12-17 Teva Pharmaceutical Industries Limited Fluvastatin sodium crystal form xiv, processes for preparing it, compositions containing it and methods of using it
EP2079736B1 (en) * 2006-12-29 2017-10-18 Rigel Pharmaceuticals, Inc. Substituted triazoles useful as axl inhibitors
MX2011006959A (es) * 2008-12-30 2011-12-06 Arqule Inc Compuestos substituidos de 5,6-dihidro-6-fenilbenzo [f] isoquinolina-2-amina.
KR20130105675A (ko) * 2010-11-25 2013-09-25 라티오팜 게엠베하 아파티닙의 신규 염 및 다형
WO2012177852A1 (en) * 2011-06-24 2012-12-27 Arqule, Inc Substituted imidazopyridinyl compounds
US9802954B2 (en) * 2011-08-24 2017-10-31 Boehringer Ingelheim International Gmbh Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma
EP2760859A1 (en) * 2011-09-30 2014-08-06 Sunshine Lake Pharma Co., Ltd Crystalline forms of azilsartan and preparation and uses thereof
TWI771280B (zh) * 2015-12-17 2022-07-21 美商亞闊股份有限公司 經取代之5,6-二氫-6-苯基苯并[f]異喹啉-2-胺化合物之固體形式
WO2017106639A1 (en) * 2015-12-17 2017-06-22 Arqule, Inc. Methods for preparing substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine
US9847831B2 (en) 2016-04-08 2017-12-19 Ciena Corporation Dual wavelenth optical time domain reflectometer systems and methods embedded in a WDM system

Similar Documents

Publication Publication Date Title
JP2018537499A5 (enExample)
JP2016041720A5 (enExample)
JP2018193382A5 (enExample)
JP2015044837A5 (enExample)
JP2021530565A5 (enExample)
JP2015524479A5 (enExample)
JP2012233154A5 (enExample)
HRP20241723T1 (hr) Kristalni toluen solvat od (s)-afoksolanera
HRP20200673T1 (hr) Makrociklički inhibitori mcl1 za liječenje raka
JP2018024682A5 (enExample)
JP2012531408A5 (enExample)
IL258052A (en) Solid configurations of isoquinolinone derivatives, process for their preparation, compositions containing them and methods of use
CA2914723C (en) Processes of making and crystalline forms of a mdm2 inhibitor
ES2613716T3 (es) Formas cristalinas de un derivado de purina
JP2020535168A5 (enExample)
PH12017501690A1 (en) Crystal of 3,5-disubstituted benzene alkynyl compound
EP3752497A1 (en) P300/cbp hat inhibitors
JP2018509457A5 (enExample)
JP2015506987A5 (enExample)
RU2021102393A (ru) Твердые формы пладиенолидпиридиновых соединений и способы их применения
RU2019105794A (ru) Кристаллогидрат соединения (2s, 3r) -изопропил 2 - (((2- (1,5-диметил-6-оксо-1,6-дигидропиридин-3-ил) -1 - ((тетрагидро-2h-пиран) -4-ил) метил) -1h-бензо [d] имидазол-5-ил) метил) амино) -3-гидроксибутаноат эдисилат
NZ742695A (en) Solid forms of substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds
JP2016530311A5 (enExample)
WO2011104637A3 (en) Crystalline forms of the tri-mesylate salt of perphenazine-gaba and process of producing the same
CN111386268A (zh) 一种urat1抑制剂的晶型及其制备方法